Table 2 Baseline demographic and clinical variables of the two groups enrolled in the study

Gender (M/F)

7/3

5/3

Age (yr)

69.18 ± 7.61

63.37 ± 6.89

p = 0.24

Height (cm)

160.91 ± 9.58

160.62 ± 14.74

p = 0.96

Weight (kg)

69.54 ± 13.33

67.62 ± 8.31

p = 0.72

Disease duration (yr)

7.82 ± 4.00

8.12 ± 2.90

p = 0.86

Falls (n)

1.45 ± 2.16

0.87 ± 0.99

p = 0.07

Levodopa (mg/day)

455.32 ± 355.49

409.19 ± 340.68

p = 0.74

Pramipexole E.R.

n = 2

n = 3

N.A.

Ropirinole E.R.

n = 3

n = 3

N.A.

Rotigotine (n = 1)

n = 1

n = 1

N.A.

Rasagiline (n = 1)

n = 2

n = 1

N.A.

Entacapone

n = 1

n = 2

N.A.

Selegiline

n = 1

n = 2

N.A.

Amantadine

n = 2

n = 2

N.A.